| Literature DB >> 28499919 |
Binbin Ma1, Zhongbo Yuan1, Li Zhang2, Peng Lv3, Ting Yang1, Jinxia Gao4, Ning Pan4, Qiong Wu5, Jiacheng Lou1, Chuanchun Han6, Bo Zhang7.
Abstract
Malignant glioma is an aggressive brain cancer that responds poorly to chemotherapy. However, the molecular mechanism underlying the development of chemoresistance in glioma is not well-understood. In this study, we show that long non-coding RNA AC023115.3 is induced by cisplatin in human glioblastoma cells and that elevated AC023115.3 promotes cisplatin-induced apoptosis by inhibiting autophagy. Further mechanistic studies revealed that AC023115.3 acts as a competing endogenous RNA for miR-26a and attenuates the inhibitory effect of miR-26a on GSK3β, a proline-directed serine-threonine kinase that promotes the degradation of Mcl1, leading to an increase in GSK3β and a decrease in autophagy. Additionally, we discovered that AC023115.3 improves chemosensitivity of glioma cells to cisplatin by regulating the miR-26a-GSK3β-Mcl1 pathway. Thus, these data indicate that the AC023115.3-miR-26a-GSK3β signalling axis plays an important role in reducing the chemoresistance of glioma.Entities:
Keywords: Autophagy; Chemoresistance; Glioblastoma; Long non-coding RNA; Mcl1
Mesh:
Substances:
Year: 2017 PMID: 28499919 DOI: 10.1016/j.bbamcr.2017.05.008
Source DB: PubMed Journal: Biochim Biophys Acta Mol Cell Res ISSN: 0167-4889 Impact factor: 4.739